These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 28899465)
21. Uncovering the Relationship Between Genes and Phenotypes Beyond the Gut in Microvillus Inclusion Disease. Sun M; Pylypenko O; Zhou Z; Xu M; Li Q; Houdusse A; van IJzendoorn SCD Cell Mol Gastroenterol Hepatol; 2024; 17(6):983-1005. PubMed ID: 38307491 [TBL] [Abstract][Full Text] [Related]
22. Loss of MYO5B Leads to Reductions in Na Engevik AC; Kaji I; Engevik MA; Meyer AR; Weis VG; Goldstein A; Hess MW; Müller T; Koepsell H; Dudeja PK; Tyska M; Huber LA; Shub MD; Ameen N; Goldenring JR Gastroenterology; 2018 Dec; 155(6):1883-1897.e10. PubMed ID: 30144427 [TBL] [Abstract][Full Text] [Related]
23. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease. Gonzales E; Taylor SA; Davit-Spraul A; Thébaut A; Thomassin N; Guettier C; Whitington PF; Jacquemin E Hepatology; 2017 Jan; 65(1):164-173. PubMed ID: 27532546 [TBL] [Abstract][Full Text] [Related]
24. Novel Hassan K; Robay A; Al-Maraghi A; Nimeri N; Azzam AB; Al Shakaki A; Hamid E; Crystal RG; Fakhro KA Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 34815247 [TBL] [Abstract][Full Text] [Related]
25. Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease. Kalashyan M; Raghunathan K; Oller H; Bayer MT; Jimenez L; Roland JT; Kolobova E; Hagen SJ; Goldsmith JD; Shub MD; Goldenring JR; Kaji I; Thiagarajah JR J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37643022 [TBL] [Abstract][Full Text] [Related]
26. Loss of syntaxin 3 causes variant microvillus inclusion disease. Wiegerinck CL; Janecke AR; Schneeberger K; Vogel GF; van Haaften-Visser DY; Escher JC; Adam R; Thöni CE; Pfaller K; Jordan AJ; Weis CA; Nijman IJ; Monroe GR; van Hasselt PM; Cutz E; Klumperman J; Clevers H; Nieuwenhuis EE; Houwen RH; van Haaften G; Hess MW; Huber LA; Stapelbroek JM; Müller T; Middendorp S Gastroenterology; 2014 Jul; 147(1):65-68.e10. PubMed ID: 24726755 [TBL] [Abstract][Full Text] [Related]
27. The localisation of the apical Par/Cdc42 polarity module is specifically affected in microvillus inclusion disease. Michaux G; Massey-Harroche D; Nicolle O; Rabant M; Brousse N; Goulet O; Le Bivic A; Ruemmele FM Biol Cell; 2016 Jan; 108(1):19-28. PubMed ID: 26526116 [TBL] [Abstract][Full Text] [Related]
29. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking. Schneeberger K; Vogel GF; Teunissen H; van Ommen DD; Begthel H; El Bouazzaoui L; van Vugt AH; Beekman JM; Klumperman J; Müller T; Janecke A; Gerner P; Huber LA; Hess MW; Clevers H; van Es JH; Nieuwenhuis EE; Middendorp S Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12408-13. PubMed ID: 26392529 [TBL] [Abstract][Full Text] [Related]
30. A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy. Li Q; Zhou Z; Sun Y; Sun C; Klappe K; van IJzendoorn SCD Cell Mol Gastroenterol Hepatol; 2022; 14(2):295-310. PubMed ID: 35421597 [TBL] [Abstract][Full Text] [Related]
31. Altered MYO5B Function Underlies Microvillus Inclusion Disease: Opportunities for Intervention at a Cellular Level. Bowman DM; Kaji I; Goldenring JR Cell Mol Gastroenterol Hepatol; 2022; 14(3):553-565. PubMed ID: 35660026 [TBL] [Abstract][Full Text] [Related]
33. Myo5b knockout mice as a model of microvillus inclusion disease. Cartón-García F; Overeem AW; Nieto R; Bazzocco S; Dopeso H; Macaya I; Bilic J; Landolfi S; Hernandez-Losa J; Schwartz S; Ramon y Cajal S; van Ijzendoorn SC; Arango D Sci Rep; 2015 Jul; 5():12312. PubMed ID: 26201991 [TBL] [Abstract][Full Text] [Related]
34. Microvillus inclusion disease: prenatal ultrasound findings, molecular diagnosis and genetic counseling of congenital diarrhea. Chen CP; Chiang MC; Wang TH; Hsueh C; Chang SD; Tsai FJ; Wang CN; Chern SR; Wang W Taiwan J Obstet Gynecol; 2010 Dec; 49(4):487-94. PubMed ID: 21199752 [TBL] [Abstract][Full Text] [Related]
35. Cell differentiation is disrupted by MYO5B loss through Wnt/Notch imbalance. Kaji I; Roland JT; Rathan-Kumar S; Engevik AC; Burman A; Goldstein AE; Watanabe M; Goldenring JR JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34197342 [TBL] [Abstract][Full Text] [Related]
36. Extraintestinal manifestations in an infant with microvillus inclusion disease: complications or features of the disease? Siahanidou T; Koutsounaki E; Skiathitou AV; Stefanaki K; Marinos E; Panajiotou I; Chouliaras G Eur J Pediatr; 2013 Sep; 172(9):1271-5. PubMed ID: 23354788 [TBL] [Abstract][Full Text] [Related]
37. Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis. van IJzendoorn SCD; Li Q; Qiu YL; Wang JS; Overeem AW Hepatology; 2020 Oct; 72(4):1461-1468. PubMed ID: 32583448 [No Abstract] [Full Text] [Related]
38. Glucocorticoids and myosin5b loss of function induce heightened PKA signaling in addition to membrane traffic defects. Forteza R; Ahsan MK; Cartón-García F; Arango D; Ameen NA; Salas PJ Mol Biol Cell; 2019 Dec; 30(26):3076-3089. PubMed ID: 31664880 [TBL] [Abstract][Full Text] [Related]
39. Challenges of Microvillus Inclusion Disease in the NICU. Badawy A; Elfadul M; Aziabi M; Ageel HI; Aqeel A Neoreviews; 2020 Sep; 21(9):e600-e604. PubMed ID: 32873653 [TBL] [Abstract][Full Text] [Related]
40. Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis. Qiu YL; Gong JY; Feng JY; Wang RX; Han J; Liu T; Lu Y; Li LT; Zhang MH; Sheps JA; Wang NL; Yan YY; Li JQ; Chen L; Borchers CH; Sipos B; Knisely AS; Ling V; Xing QH; Wang JS Hepatology; 2017 May; 65(5):1655-1669. PubMed ID: 28027573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]